This comprehensive program brings together leading experts in structural heart disease, imaging, electrophysiology, and interventional cardiology to explore the evolving landscape of mitral and tricuspid valve management. Through a blend of state-of-the-art lectures and case-based discussions, participants will examine the complex interplay between valvular pathology and cardiac arrhythmias, review cutting-edge transcatheter and surgical therapies, and deepen their understanding of advanced conditions such as ischemic MR, torrential TR, and HOCM-related mitral disease. Emphasizing multimodality imaging, evidence-based decision-making, and multidisciplinary collaboration, the program equips clinicians with the knowledge and practical strategies needed to navigate challenging scenarios and optimize outcomes for patients with complex structural heart disease.
By attending, participants will be able to:
- Integrate multimodality imaging into valvular and arrhythmic assessment
- Apply contemporary evidence to the management of mitral and tricuspid valve disease
- Explore the interplay between valvular disease and cardiac arrhythmias
- Develop expertise in managing complex and high-risk clinical scenarios
- Evaluate emerging technologies and evolving best practices in structural heart disease
Who Should Attend?
This course is intended for cardiothoracic surgeons, cardiologists, interventional cardiologists, internists, and all health care professionals involved in the evaluation, diagnosis, and management of patients with mitral and/or tricuspid valve disease.